Glutathione: Research Applications

Aplicacoes de Pesquisa

Glutathione is investigated across a broad spectrum of research domains, with evidence spanning preclinical modelo animals to randomizado controlled ensaios clinicos:

1. Neurodegenerative Diseases (Parkinson's, Alzheimer's)

GSH depletion no(a) substantia nigra is one do(a) earliest biochemical changes in Parkinson's disease, preceding mitochondrial Complex I dysfunction and dopaminergic neuron loss. Intranasal GSH (200–600 mg/day) demonstrated significant improvement in UPDRS Total scores (-4.6 points, P = 0.0025) in a Phase IIb RCT, e um(a) single 200 mg intranasal dose aumentou brain GSH levels >200% within 45 minutes (P < 0.001) as medido(a) by magnetic resonance spectroscopy.[11][5][13]

2. Hepatoprotection (NAFLD, NASH, Cirrhosis)

GSH is extensively studied for its hepatoprotective effects. Oral GSH (300 mg/day for 4 months) reduziu significativamente ALT levels (p < 0.05) in NAFLD subjects. In NASH subjects, 300 mg/day for 3 months diminuiu ambos(as) ALT and 8-OHdG (DNA oxidative damage marker) significantly. No entanto, 500 mg/day GSH por 12 semanas showed no significant effect in liver cirrhosis.[8]

3. Dermatology & Skin Research

Estudo	Intervention	Key Result	Ref
Weschawalit et al. (2017)	250 mg oral GSH or GSSG/day, 12 weeks	Significant wrinkle reduction (P = 0.006); aumentou skin elasticity; melanin index reduction in >40 year group	[19]
Arjinpathana et al. (2012)	500 mg oral GSH/day, 4 weeks	Significant melanin index reduction in sun-exposed areas (face/wrists) vs placebo	[2]
Watanabe et al. (2014)	2% GSSG lotion, duas vezes ao dia, 10 weeks	Significant reduction in melanin index (p < 0.05), TEWL (p < 0.05), and wrinkles (p < 0.01)	[18]

4. Diabetes & Metabolic Syndrome

Research destaca a correlation between GSH insufficiency and T2DM complications. Oral GSH (1000 mg/day, 3 weeks) aumentou significativamente whole-body sensibilidade a insulina in obese males with and sem T2DM (NCT02948673). In a larger trial (n=360), 500 mg/day for 6 months as adjunct therapy diminuiu significativamente oxidative damage markers and melhorou HbA1c in subjects >55 years.[16]

5. Oncology & Chemotherapy Support

IV glutathione (1.5 g/m²) administered before cisplatin chemotherapy demonstrated neuroprotetor(a) effects in randomizado trials of advanced gastric cancer and ovarian cancer, reducing neurotoxicity and nephrotoxicity sem compromising antineoplastic efficacy.[4][15]

6. Respiratory Conditions (Cystic Fibrosis, IPF)

Inhaled/aerosolized glutathione (600 mg BID) is investigated for replenishing GSH no(a) epitelial lining fluid do(a) lungs. Oral reduziu L-glutathione melhorou growth in pediatric cystic fibrose subjects. Results on FEV1 improvement have been mixed across studies.[17]

7. Viral Infections & Immune Function

GSH depletion is linked to impaired host resposta imunologicas and severe outcomes in HIV and COVID-19. Liposomal glutathione supplementation elevated body stores of GSH and markers of funcao imunologica (incluindo natural killer cell activity) in adultos saudaveis.[14]

8. Male Infertility

Intramuscular GSH (600 mg) was studied in a controlado por placebo, duplo-cego crossover trial for male infertility, targeting estresse oxidativo in seminal plasma que damages sperm DNA and motility.[10]

9. Cardiovascular Aging

In aged Wistar rats, intraperitoneal GSH (52 mg/kg) aumentou total heart glutathione by 40% (p = 0.0027), reduziu superoxide generation 2.5-fold, and restaurou endothelium-dependent vasorelaxation, demonstrating significant cardiovascular rejuvenation potential.[3]